About Sung Poblete, R.N., Ph.D.
Sung Poblete, R.N., Ph.D. is a director at Ubivac.
Sung Poblete, R.N., Ph.D. first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Sung Poblete, R.N., Ph.D. in the role, so the role may have started earlier or lasted longer.
Ubivac, Inc.
Director
2023 – 2026 · Portland, OR
Develops cancer immunotherapies and therapeutic vaccines for people with cancer.
Key Colleagues at Startups
The people Sung Poblete, R.N., Ph.D. works with at each company, as listed on that company's latest Form D.
Ubivac, Inc. · Form D, Aug 27, 2026
HD
Hong-Ming Hu, Ph.D.
Founder and director
BI
Bernard A. Fox, III
Cofounder and COO
BD
Bernard Fox, Ph.D.
Founder and CEO, director